James A. Monn

909 total citations
8 papers, 757 citations indexed

About

James A. Monn is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, James A. Monn has authored 8 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 2 papers in Cognitive Neuroscience. Recurrent topics in James A. Monn's work include Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (5 papers) and Ion channel regulation and function (4 papers). James A. Monn is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (5 papers) and Ion channel regulation and function (4 papers). James A. Monn collaborates with scholars based in United States, United Kingdom and Switzerland. James A. Monn's co-authors include Darryle D. Schoepp, Jayne Cartmell, Rebecca A. Wright, Darryle D. Schoepp, Gerard J. Marek, George K. Aghajanian, Giuseppe Battaglia, James McCulloch, Marc A. Soriano and D Lodge and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, European Journal of Pharmacology and Neuroscience Letters.

In The Last Decade

James A. Monn

8 papers receiving 745 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James A. Monn United States	8	703	430	154	80	53	8	757
Audrey Hashim United States	21	695 1.0×	503 1.2×	93 0.6×	82 1.0×	37 0.7×	36	948
Stephen N. Mitchell United Kingdom	17	527 0.7×	313 0.7×	234 1.5×	80 1.0×	48 0.9×	26	774
S.N. Mitchell United Kingdom	15	610 0.9×	512 1.2×	179 1.2×	100 1.3×	61 1.2×	19	949
H. B. Niznik Canada	7	778 1.1×	367 0.9×	145 0.9×	27 0.3×	30 0.6×	7	1.0k
Cindy Achat‐Mendes United States	12	426 0.6×	212 0.5×	137 0.9×	42 0.5×	41 0.8×	21	591
Lucinda J. Steward United Kingdom	17	536 0.8×	502 1.2×	127 0.8×	81 1.0×	107 2.0×	25	903
Roland Mory Switzerland	6	476 0.7×	399 0.9×	75 0.5×	74 0.9×	45 0.8×	6	659
Aric Madayag United States	12	444 0.6×	215 0.5×	115 0.7×	87 1.1×	62 1.2×	13	583
Valérie Pasteau France	11	495 0.7×	459 1.1×	107 0.7×	120 1.5×	52 1.0×	12	918
Giuseppe Giannotti Italy	19	509 0.7×	200 0.5×	148 1.0×	85 1.1×	61 1.2×	34	652

Countries citing papers authored by James A. Monn

Since Specialization

Citations

This map shows the geographic impact of James A. Monn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Monn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Monn more than expected).

Fields of papers citing papers by James A. Monn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Monn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Monn. The network helps show where James A. Monn may publish in the future.

Co-authorship network of co-authors of James A. Monn

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Monn. A scholar is included among the top collaborators of James A. Monn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Monn. James A. Monn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Coplan, Jeremy D., Sanjay J. Mathew, Eric L. Smith, et al.. (2001). Effects of LY354740, a Novel Glutamatergic Metabotropic Agonist, on Nonhuman Primate Hypothalamic-Pituitary-Adrenal Axis and Noradrenergic Function. CNS Spectrums. 6(7). 607–617. 14 indexed citations

Cartmell, Jayne, James A. Monn, & Darryle D. Schoepp. (2000). The mGlu2/3 receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing. European Journal of Pharmacology. 400(2-3). 221–224. 81 indexed citations

Marek, Gerard J., Rebecca A. Wright, Darryle D. Schoepp, James A. Monn, & George K. Aghajanian. (2000). Physiological Antagonism between 5-Hydroxytryptamine2A and Group II Metabotropic Glutamate Receptors in Prefrontal Cortex. Journal of Pharmacology and Experimental Therapeutics. 292(1). 76–87. 235 indexed citations

Cartmell, Jayne, James A. Monn, & Darryle D. Schoepp. (1999). The Metabotropic Glutamate 2/3 Receptor Agonists LY354740 and LY379268 Selectively Attenuate Phencyclidine versus d-Amphetamine Motor Behaviors in Rats. Journal of Pharmacology and Experimental Therapeutics. 291(1). 161–170. 228 indexed citations

Schoepp, Darryle D., Bryan G. Johnson, Rebecca A. Wright, Craig R. Salhoff, & James A. Monn. (1998). Potent, stereoselective, and brain region selective modulation of second messengers in the rat brain by (+)LY354740, a novel group II metabotropic glutamate receptor agonist. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(2). 175–180. 19 indexed citations

Valli, Matthew J., Darryle D. Schoepp, Rebecca A. Wright, et al.. (1998). Synthesis and metabotropic glutamate receptor antagonist activity of N1-substituted analogs of 2R,4R-4-aminopyrrolidine-2,4-dicarboxylic acid. Bioorganic & Medicinal Chemistry Letters. 8(15). 1985–1990. 11 indexed citations

Soriano, Marc A., et al.. (1998). Effects of the selective metabotropic glutamate agonist LY354740 in a rat model of permanent ischaemia. Neuroscience Letters. 254(2). 121–123. 34 indexed citations

Battaglia, Giuseppe, James A. Monn, & Darryle D. Schoepp. (1997). In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats. Neuroscience Letters. 229(3). 161–164. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact